Published in Nucleic Acids Res on April 26, 2012
Oligopeptide m13 phage display in pathogen research. Viruses (2013) 0.81
Multivalent pIX phage display selects for distinct and improved antibody properties. Sci Rep (2016) 0.75
Production of single-stranded plasmid DNA. Methods Enzymol (1987) 39.38
By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol (1991) 6.62
Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci U S A (1990) 6.34
Context effects: translation of UAG codon by suppressor tRNA is affected by the sequence following UAG in the message. J Mol Biol (1983) 2.62
Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol (2011) 2.41
A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem (1999) 2.15
By-passing immunization: building high affinity human antibodies by chain shuffling. Biotechnology (N Y) (1992) 2.05
Antibodies from phage antibody libraries. J Immunol Methods (2004) 1.75
A helper phage to improve single-chain antibody presentation in phage display. Nat Biotechnol (2001) 1.72
Selecting high-affinity binding proteins by monovalent phage display. Biochemistry (1991) 1.66
Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol (2004) 1.56
Inheritance of antibody specificity V. Anti-2-phenyloxazolone in the mouse. J Exp Med (1978) 1.55
Progress in phage display: evolution of the technique and its application. Cell Mol Life Sci (2010) 1.43
Filamentous bacteriophage: biology, phage display and nanotechnology applications. Curr Issues Mol Biol (2011) 1.33
Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J Mol Biol (1995) 1.24
Toward selection of internalizing antibodies from phage libraries. Biochem Biophys Res Commun (1999) 1.23
A method for the generation of combinatorial antibody libraries using pIX phage display. Proc Natl Acad Sci U S A (2002) 1.18
Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays. Proc Natl Acad Sci U S A (1999) 1.18
Phage versus phagemid libraries for generation of human monoclonal antibodies. J Mol Biol (2002) 1.18
Morphogenesis of filamentous bacteriophage f1: orientation of extrusion and production of polyphage. Virology (1983) 1.12
Location of filamentous phage minor coat proteins in phage and in infected cells. J Mol Biol (1995) 1.10
On the influence of vector design on antibody phage display. J Biotechnol (2006) 1.07
A novel helper phage that improves phage display selection efficiency by preventing the amplification of phages without recombinant protein. Nucleic Acids Res (2003) 1.06
Generating recombinant antibodies to the complete human proteome. Trends Biotechnol (2010) 1.04
The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody. Proc Natl Acad Sci U S A (1997) 1.04
Enrichment of open reading frames presented on bacteriophage M13 using hyperphage. Biotechniques (2006) 1.00
Genes VI, VII, and IX of phage M13 code for minor capsid proteins of the virion. Proc Natl Acad Sci U S A (1981) 0.99
An improved helper phage system for efficient isolation of specific antibody molecules in phage display. Nucleic Acids Res (2002) 0.97
De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins. J Mol Biol (2010) 0.97
Cell targeted phagemid rescued by preselected landscape phage. Gene (2004) 0.95
A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype-specific, major histocompatibility complex-restricted T cell clones. Eur J Immunol (1990) 0.93
Reliable titration of filamentous bacteriophages independent of pIII fusion moiety and genome size by using trypsin to restore wild-type pIII phenotype. Biotechniques (2008) 0.92
Evaluation of antibodies fused to minor coat protein III and major coat protein VIII of bacteriophage M13. Gene (1995) 0.91
Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region. Eur J Immunol (1986) 0.89
Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons. Scand J Immunol (1990) 0.89
Multivalent display system on filamentous bacteriophage pVII minor coat protein. J Immunol Methods (2005) 0.87
A new helper phage and phagemid vector system improves viral display of antibody Fab fragments and avoids propagation of insert-less virions. J Immunol Methods (2003) 0.87
Expanding the versatility of phage display II: improved affinity selection of folded domains on protein VII and IX of the filamentous phage. PLoS One (2011) 0.86
Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance. Protein Eng Des Sel (2007) 0.85
Antibody Fab display and selection through fusion to the pIX coat protein of filamentous phage. J Immunol Methods (2010) 0.83
Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J Immunol (1996) 0.83
New display vector reduces biological bias for expression of antibodies in E. coli. Gene (2006) 0.82
Differential segmental flexibility and reach dictate the antigen binding mode of chimeric IgD and IgM: implications for the function of the B cell receptor. J Immunol (2004) 0.81
Oligovalent Fab display on M13 phage improved by directed evolution. Mol Biotechnol (2010) 0.79
Rapid titration of multiple samples of filamentous bacteriophage (M13) on nitrocellulose filters. Biotechniques (2000) 0.78
Membrane insertion and assembly of epitope-tagged gp9 at the tip of the M13 phage. BMC Microbiol (2011) 0.78
Protein III-based single-chain antibody phage display using bacterial cells bearing an additional genome of a gene-III-lacking helper phage. Biotechniques (2007) 0.77
An optimized procedure for efficient phage display of antibody fragments with a low folding efficiency. Protein Expr Purif (2009) 0.76
Selection dynamic of Escherichia coli host in M13 combinatorial peptide phage display libraries. Biosci Biotechnol Biochem (2011) 0.76
Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J (2006) 3.07
Primary antitumor immune response mediated by CD4+ T cells. Immunity (2005) 2.72
Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov (2003) 2.13
In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn. Transfusion (2007) 1.50
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun (2011) 1.49
Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. J Biol Chem (2009) 1.44
Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci U S A (2011) 1.44
Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type. J Immunol (2011) 1.39
The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. Eur J Immunol (2006) 1.32
Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res (2003) 1.23
The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics. Drug Metab Pharmacokinet (2009) 1.22
Three-dimensional reconstruction of bacteria with a complex endomembrane system. PLoS Biol (2013) 1.19
Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nat Commun (2012) 1.19
Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells. Proc Natl Acad Sci U S A (2009) 1.17
Cardiomyopathy syndrome of atlantic salmon (Salmo salar L.) is caused by a double-stranded RNA virus of the Totiviridae family. J Virol (2011) 1.16
Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J Immunol (2003) 1.13
Formation of the arterivirus replication/transcription complex: a key role for nonstructural protein 3 in the remodeling of intracellular membranes. J Virol (2008) 1.12
Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). J Immunol (2008) 1.12
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun (2011) 1.11
Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol (2011) 1.11
Relationship between vaccinia virus intracellular cores, early mRNAs, and DNA replication sites. J Virol (2002) 1.09
A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease. PLoS One (2012) 1.07
Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells. J Immunol (2005) 1.05
Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med (2007) 1.05
Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells. Cancer Res (2009) 1.03
Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells. J Immunol Methods (2005) 1.03
Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. Cell Rep (2013) 1.02
Functional analyses of pilin-like proteins from Francisella tularensis: complementation of type IV pilus phenotypes in Neisseria gonorrhoeae. Microbiology (2009) 1.01
Substitutions in the N-terminal alpha helical spine of Neisseria gonorrhoeae pilin affect Type IV pilus assembly, dynamics and associated functions. Mol Microbiol (2006) 1.01
Delivery of antigen to CD40 induces protective immune responses against tumors. J Immunol (2007) 1.01
The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma. Br J Haematol (2012) 1.00
The Vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions' core. J Virol (2002) 0.99
Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes. J Cell Sci (2013) 0.98
Effective phagocytosis of low Her2 tumor cell lines with engineered, aglycosylated IgG displaying high FcγRIIa affinity and selectivity. ACS Chem Biol (2012) 0.97
FcRn binding properties of an abnormal truncated analbuminemic albumin variant. Clin Biochem (2009) 0.97
Pseudomonas aeruginosa Type IV pilus expression in Neisseria gonorrhoeae: effects of pilin subunit composition on function and organelle dynamics. J Bacteriol (2007) 0.96
Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma. PLoS One (2012) 0.96
Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues. FEBS J (2008) 0.94
Effects of silver and gold nanoparticles on rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquat Toxicol (2009) 0.94
Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences. Blood (2007) 0.94
A practical approach to T-cell receptor cloning and expression. PLoS One (2011) 0.93
Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor. Eur J Immunol (2009) 0.93
A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. Int Immunol (2002) 0.93
MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production. J Immunol (2004) 0.93
Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies. Blood (2003) 0.93
Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol Ther (2004) 0.93
Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus. Eur J Immunol (2014) 0.93
Covalent antibody display--an in vitro antibody-DNA library selection system. Nucleic Acids Res (2005) 0.92
Reliable titration of filamentous bacteriophages independent of pIII fusion moiety and genome size by using trypsin to restore wild-type pIII phenotype. Biotechniques (2008) 0.92
A strategy for bacterial production of a soluble functional human neonatal Fc receptor. J Immunol Methods (2007) 0.92
TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques. J Immunol (2014) 0.91
DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells. Mol Ther (2006) 0.91
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis. J Leukoc Biol (2004) 0.90
Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1. Biochem Biophys Res Commun (2005) 0.90
Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. J Biol Chem (2012) 0.90
The N-terminal flanking region of the TRP2360-368 melanoma antigen determines proteasome activator PA28 requirement for epitope liberation. J Biol Chem (2007) 0.89
Single-chain variable fragment albumin fusions bind the neonatal Fc receptor (FcRn) in a species-dependent manner: implications for in vivo half-life evaluation of albumin fusion therapeutics. J Biol Chem (2013) 0.88
Uptake and effects of manufactured silver nanoparticles in rainbow trout (Oncorhynchus mykiss) gill cells. Aquat Toxicol (2010) 0.88
Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4. Biol Chem (2009) 0.88
Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model. BMC Cancer (2011) 0.88
Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation. Biophys J (2007) 0.87
The carboxyl-terminal domains of IgA and IgM direct isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor. J Biol Chem (2002) 0.87
Chimeric anti-CD14 IGG2/4 Hybrid antibodies for therapeutic intervention in pig and human models of inflammation. J Immunol (2013) 0.87
Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding. J Biol Chem (2014) 0.87
Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells. Eur J Immunol (2014) 0.87
The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation. Immunol Cell Biol (2010) 0.86
Expanding the versatility of phage display II: improved affinity selection of folded domains on protein VII and IX of the filamentous phage. PLoS One (2011) 0.86
Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma. Immunol Lett (2013) 0.86
Polymeric human Fc-fusion proteins with modified effector functions. Sci Rep (2011) 0.86
DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza. J Immunol (2013) 0.85
A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells. Eur J Immunol (2006) 0.85
A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance. Protein Eng Des Sel (2012) 0.85
A model for cancer-suppressive inflammation. Oncoimmunology (2012) 0.85
Molecular profiling of tumor-specific TH1 cells activated in vivo. Oncoimmunology (2013) 0.84
Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am J Pathol (2009) 0.84
Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells. Front Oncol (2012) 0.84
A receptor-mediated mechanism to support clinical observation of altered albumin variants. Clin Chem (2007) 0.83
Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice. Blood (2012) 0.83
The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype. PLoS One (2013) 0.82
Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines. Vaccine (2010) 0.82
Insights into type IV pilus biogenesis and dynamics from genetic analysis of a C-terminally tagged pilin: a role for O-linked glycosylation. Mol Microbiol (2012) 0.82
Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies. J Immunol (2002) 0.82
Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. J Clin Invest (2015) 0.82
Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing. Eur J Haematol (2011) 0.82
Next generation phage display by use of pVII and pIX as display scaffolds. Methods (2012) 0.81
Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates. Vaccine (2007) 0.81
Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display. Sci Rep (2013) 0.81
Identification of a polymeric Ig receptor binding phage-displayed peptide that exploits epithelial transcytosis without dimeric IgA competition. J Biol Chem (2006) 0.81
CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo. Cancer Immunol Immunother (2004) 0.81
Phenotypical analysis of atypical PKCs in vivo function display a compensatory system at mouse embryonic day 7.5. PLoS One (2013) 0.81
Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment. ACS Nano (2014) 0.81
The cytoplasmic tail of invariant chain modulates antigen processing and presentation. Eur J Immunol (2003) 0.81